These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 16491095)
1. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure. Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cardiac activity by tachykinins in the rat substantia nigra. Lessard A; Couture R Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252 [TBL] [Abstract][Full Text] [Related]
3. Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Lessard A; Campos MM; Neugebauer W; Couture R Br J Pharmacol; 2003 Feb; 138(4):554-63. PubMed ID: 12598409 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats. Cloutier F; de Sousa Buck H; Ongali B; Couture R Br J Pharmacol; 2002 Apr; 135(7):1641-54. PubMed ID: 11934804 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Cellier E; Barbot L; Regoli D; Couture R Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960 [TBL] [Abstract][Full Text] [Related]
6. Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats. De Brito Gariepy H; Couture R Br J Pharmacol; 2010 Dec; 161(8):1868-84. PubMed ID: 20804497 [TBL] [Abstract][Full Text] [Related]
7. Neurokinin-1 receptors and spinal cord control of blood pressure in spontaneously hypertensive rats. Solomon SG; Llewellyn-Smith IJ; Minson JB; Arnolda LF; Chalmers JP; Pilowsky PM Brain Res; 1999 Jan; 815(1):116-20. PubMed ID: 9974130 [TBL] [Abstract][Full Text] [Related]
8. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903 [TBL] [Abstract][Full Text] [Related]
9. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Deschamps K; Couture R Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109 [TBL] [Abstract][Full Text] [Related]
10. Increased ganglionic responses to substance P in hypertensive rats due to upregulation of NK(1) receptors. Schoborg RV; Hoover DB; Tompkins JD; Hancock JC Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1685-94. PubMed ID: 11049850 [TBL] [Abstract][Full Text] [Related]
11. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat. Brouillette J; Couture R Br J Pharmacol; 2002 Aug; 136(8):1169-77. PubMed ID: 12163350 [TBL] [Abstract][Full Text] [Related]
13. SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat. Couture R; Toma N; Barbot L Life Sci; 2000; 66(1):51-65. PubMed ID: 10658924 [TBL] [Abstract][Full Text] [Related]
14. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P; Regoli D; Couture R Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304 [TBL] [Abstract][Full Text] [Related]
16. Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat. Lessard A; Laurin M; Yamaguchi N; Couture R Eur J Pharmacol; 2004 Feb; 486(1):75-83. PubMed ID: 14751411 [TBL] [Abstract][Full Text] [Related]
17. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig. Roccon A; Marchionni D; Nisato D Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331 [TBL] [Abstract][Full Text] [Related]
18. Compensatory mechanisms to maintain blood pressure in paraplegic rats: implication of central tachykinin NK-1 and NK-3 receptors? Cloutier F; Lauschke JL; Carrive P Neuropeptides; 2010 Apr; 44(2):199-207. PubMed ID: 20096457 [TBL] [Abstract][Full Text] [Related]
19. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat. Cellier E; Barbot L; Iyengar S; Couture R Br J Pharmacol; 1999 Jun; 127(3):717-28. PubMed ID: 10401563 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects of tachykinin agonists on sympathetic ganglia of spontaneously hypertensive rats. Tompkins JD; Hancock JC Auton Neurosci; 2002 Apr; 97(1):26-34. PubMed ID: 12036183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]